alexa Abstract | Multiple Daily Injection of Insulin Using Insulin Detemir in Type 1 Diabetic Saudi Children

Current Pediatric Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Detemir (levemir™) insulin is a recently approved, long acting insulin analog that is increasingly being used in children and adults with diabetes. Ten Saudi children with type 1 diabetes mellitus were selected and started on determir-based basal-bolus insulin therapy. This study showed that basal-bolus insulin regimen is effective in improving the metabolic control in type 1 diabetic Saudi children. The results of this local experiment are encouraging to implement this mode of intensive insulin therapy in all candidate diabetic Saudi children

To read the full article Peer-reviewed Article PDF image

Author(s): Bassam S BinAbbas


Type 1 diabetes, basal-bolus insulin regimen, Detemir insulin

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version